Scandinavian ChemoTech AB Class B (NEEMS.B) Stock Statistics & Valuation Metrics

Scandinavian ChemoTech AB Class B has a market cap or net worth of kr87.31M. The enterprise value is kr92.22.

Scandinavian ChemoTech AB Class B has 23,802,313 shares outstanding. The number of shares has decreased by -2.65% in one year.

Scandinavian ChemoTech AB Class B’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Scandinavian ChemoTech AB Class B is ―. Scandinavian ChemoTech AB Class B’s PEG ratio is 0.35.

In the last 12 months, Scandinavian ChemoTech AB Class B had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Scandinavian ChemoTech AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Scandinavian ChemoTech AB Class B upcoming earnings date is Oct 27, 2026, TBA (Confirmed).

Scandinavian ChemoTech AB Class B as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Scandinavian ChemoTech AB Class B has paid ― in taxes.

Scandinavian ChemoTech AB Class B EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Scandinavian ChemoTech AB Class B has ― in cash and marketable securities with kr0.00 in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Scandinavian ChemoTech AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―